GES: A validated simple score to predict the risk of HCC in patients with HCV‐GT4‐associated advanced liver fibrosis after oral antivirals-Reference-Cited by-同舟云学术

GES: A validated simple score to predict the risk of HCC in patients with HCV‐GT4‐associated advanced liver fibrosis after oral antivirals

Published:2020-10-28 Issue:11 Volume:40 Page:2828-2833
ISSN:1478-3223
Container-title:Liver International
language:en
Short-container-title:Liver Int.

Author:

Shiha Gamal¹²^ORCID,Waked Imam³,Soliman Reham¹⁴^ORCID,Elbasiony Mohamed¹²,Gomaa Asmaa³^ORCID,Mikhail Nabiel N. H.¹⁵^ORCID,Eslam Mohammed⁶^ORCID

Affiliation:

1. Egyptian Liver Research Institute and Hospital (ELRIAH) Mansoura Egypt

2. Hepatology and Gastroenterology Unit Internal Medicine Department Faculty of Medicine Mansoura University Mansoura Egypt

3. Hepatology Department National Liver Institute Menoufia University Shebeen Elkom Egypt

4. Tropical Medicine Department Faculty of Medicine Port Said University Port Said Egypt

5. Biostatistics and Cancer Epidemiology Department South Egypt Cancer InstituteAssiut University Asyut Egypt

6. Storr Liver Centre Westmead Institute for Medical Research Westmead Hospital and University of Sydney Sydney NSW Australia

Publisher

Wiley

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/liv.14666

Reference18 articles.

1. The trends in incidence of primary liver cancer caused by specific etiologies: Results from the Global Burden of Disease Study 2016 and implications for liver cancer prevention

2. Increased Risk for Hepatocellular Carcinoma Persists Up to 10 Years After HCV Eradication in Patients With Baseline Cirrhosis or High FIB-4 Scores

3. Early Detection, Curative Treatment, and Survival Rates for Hepatocellular Carcinoma Surveillance in Patients with Cirrhosis: A Meta-analysis

4. HCV Guidance: Recommendations for Testing Managing and Treating Hepatitis C. December 10 2019 © 2019 American Association for the Study of Liver Diseases and the Infectious Diseases Society of America.https://www.hcvguidelines.org/

5. EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predictive performance of hepatocellular carcinoma risk scores in chronic hepatitis C patients with advanced fibrosis after achieving sustained virological response: Insights from European Association for the study of the Liver Policy recommendations;European Journal of Internal Medicine;2024-09

2. A literature review of genetics and epigenetics of HCV-related hepatocellular carcinoma: translational impact;Hepatobiliary Surgery and Nutrition;2024-08

3. High incidence of hepatocarcinoma in patients with advanced fibrosis treated with direct-acting antiviral agents for hepatitis C: A real-world retrospective study;Clinics and Research in Hepatology and Gastroenterology;2024-08

4. Validation of SMART model for HCC risk stratification in genotype -4 HCV patients following SVR and its comparison with GES score;Journal of Hepatology;2024-05

5. Comparison of six hepatocellular carcinoma prediction models in Japanese patients after sustained virologic response undergoing rigorous surveillance for hepatocellular carcinoma;Journal of Gastroenterology and Hepatology;2024-01-30